AOP2 AND ATHEROSCLEROSIS RESISTANCE AND MICE
AOP2 和动脉粥样硬化抵抗与小鼠
基本信息
- 批准号:6139127
- 负责人:
- 金额:$ 3.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-12-12 至
- 项目状态:未结题
- 来源:
- 关键词:animal breeding atherosclerosis disease /disorder model gene expression genetic promoter element genetic susceptibility genetically modified animals in situ hybridization laboratory mouse model design /development molecular cloning nucleic acid sequence oxidative stress polymerase chain reaction tissue /cell culture
项目摘要
DESCRIPTION
Previous studies from our laboratory have demonstrated that susceptibility
to atherosclerosis differs significantly between inbred strains of mice,
suggesting a strong genetic component to the disease. Athl is a
quantitative trait locus that we found to be associated with decreased
plasma HDL-cholesterol levels and increased atherosclerotic lesion
formation in susceptible strains of mice when fed a high fat diet. We have
recently identified a Athl candidate gene, Aop2, which is a member of the
thiol-specific antioxidant family. We believe Aop2 mediates protection
from atherosclerosis based on its chromosomal co-localization with Athl,
mRNA induction by high fat diet, amino acid and expression differences
between resistant and susceptible strains, and the proposed role of LDL
oxidation in the pathogenesis of atherosclerosis. I propose three specific
aims toward the characterization of AOP2 in atherosclerosis resistance: 1)
obtain definitive proof that AOP2 confers resistance to atherosclerosis by
transgenic rescue; 2) characterize expression of AOP2 in the arterial
wall; and 3) determine the molecular basis for the regulatory differences
observed between atherosclerosis resistant and susceptible strains.
描述
我们实验室以前的研究表明,
对动脉粥样硬化的影响在近交系小鼠之间有显著差异,
这表明这种疾病有很强的遗传因素Athl是一个
数量性状基因座,我们发现与减少
血浆HDL-胆固醇水平和动脉粥样硬化病变增加
当喂食高脂肪饮食时,在易感品系的小鼠中形成。我们有
最近发现了一个Athl候选基因Aop 2,它是一个成员,
巯基特异性抗氧化剂家族。我们认为Aop 2介导了保护作用,
基于其与Athl的染色体共定位,
高脂饲料对mRNA的诱导、氨基酸及表达差异
耐药和敏感菌株之间的关系,以及LDL的作用
氧化在动脉粥样硬化的发病机制。我建议三个具体的
目的在于表征AOP 2在动脉粥样硬化抗性中的作用:1)
获得AOP 2赋予抗动脉粥样硬化的确切证据,
转基因拯救; 2)表征动脉中AOP 2的表达
壁;和3)确定调节差异的分子基础
观察动脉粥样硬化抵抗和敏感株之间。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shelley A Phelan其他文献
Shelley A Phelan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shelley A Phelan', 18)}}的其他基金
AOP2 AND ATHEROSCLEROSIS RESISTANCE AND MICE
AOP2 和动脉粥样硬化抵抗与小鼠
- 批准号:
6343492 - 财政年份:2000
- 资助金额:
$ 3.67万 - 项目类别:
AOP2 AND ATHEROSCLEROSIS RESISTANCE AND MICE
AOP2 和动脉粥样硬化抵抗与小鼠
- 批准号:
2767602 - 财政年份:1999
- 资助金额:
$ 3.67万 - 项目类别:
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 3.67万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
- 批准号:
10537602 - 财政年份:2023
- 资助金额:
$ 3.67万 - 项目类别:
Targeted multimodal stimuli-responsive nanogels for atherosclerosis imaging and therapy
用于动脉粥样硬化成像和治疗的靶向多模式刺激响应纳米凝胶
- 批准号:
2880683 - 财政年份:2023
- 资助金额:
$ 3.67万 - 项目类别:
Studentship
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
- 批准号:
23K15842 - 财政年份:2023
- 资助金额:
$ 3.67万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
- 批准号:
10652788 - 财政年份:2023
- 资助金额:
$ 3.67万 - 项目类别:
From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosis
GWAS 位点从基因型到表型:REST 在动脉粥样硬化中的作用
- 批准号:
10570469 - 财政年份:2023
- 资助金额:
$ 3.67万 - 项目类别:
Alcohol Regulation of Endothelial Plasticity in Atherosclerosis
酒精对动脉粥样硬化内皮可塑性的调节
- 批准号:
10585070 - 财政年份:2023
- 资助金额:
$ 3.67万 - 项目类别:
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis
细胞外囊泡相关 MicroRNA 在 HIV 相关动脉粥样硬化中的作用
- 批准号:
10619831 - 财政年份:2023
- 资助金额:
$ 3.67万 - 项目类别:
MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS - TOPMED
动脉粥样硬化的多种族研究 - TOPMED
- 批准号:
10974007 - 财政年份:2023
- 资助金额:
$ 3.67万 - 项目类别: